Public Employees Retirement System of Ohio Takes $4.13 Million Position in Solventum Corporation $SOLV

Key Points

• Ohio’s public employees’ retirement system acquired 53,551 Solventum shares in the second quarter, valued at approximately $4.13 million. Several other institutional investors also increased their positions.
• Solventum reported quarterly EPS of $2.55, beating estimates of $1.91, while revenue reached $2.21 billion and increased 2.2% year over year. The company provided fiscal 2026 EPS guidance of $7.10–$7.20.
• SOLV recently traded at $92.44, near its 52-week high, and analysts’ consensus rating is “Moderate Buy” with an average price target of $91.64; several firms raised their targets, including Piper Sandler to $105.

Public Employees Retirement System of Ohio bought a new stake in Solventum Corporation (NYSE:SOLV - Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 53,551 shares of the company's stock, valued at approximately $4,131,000.

Other institutional investors have also recently bought and sold shares of the company. BOKF NA lifted its position in shares of Solventum by 6.9% in the third quarter. BOKF NA now owns 2,193 shares of the company's stock valued at $160,000 after buying an additional 141 shares during the last quarter. Smartleaf Asset Management LLC lifted its holdings in Solventum by 23.6% during the 4th quarter. Smartleaf Asset Management LLC now owns 744 shares of the company's stock valued at $60,000 after purchasing an additional 142 shares during the last quarter. NewEdge Advisors LLC boosted its position in Solventum by 2.2% during the first quarter. NewEdge Advisors LLC now owns 6,707 shares of the company's stock worth $438,000 after purchasing an additional 144 shares during the period. Deseret Mutual Benefit Administrators boosted its position in Solventum by 39.5% during the fourth quarter. Deseret Mutual Benefit Administrators now owns 516 shares of the company's stock worth $41,000 after purchasing an additional 146 shares during the period. Finally, HB Wealth Management LLC increased its holdings in shares of Solventum by 3.5% in the first quarter. HB Wealth Management LLC now owns 4,292 shares of the company's stock valued at $280,000 after purchasing an additional 147 shares during the last quarter.

Solventum Trading Up 0.6%

SOLV stock opened at $92.44 on Friday. Solventum Corporation has a 52 week low of $62.38 and a 52 week high of $94.16. The company has a market capitalization of $15.74 billion, a PE ratio of 11.30, a price-to-earnings-growth ratio of 1.43 and a beta of 0.61. The company's 50-day simple moving average is $83.76 and its 200 day simple moving average is $75.90. The company has a debt-to-equity ratio of 1.00, a quick ratio of 0.74 and a current ratio of 1.02.

Solventum (NYSE:SOLV - Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $2.55 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.91 by $0.64. Solventum had a net margin of 17.26% and a return on equity of 25.09%. The firm had revenue of $2.21 billion during the quarter, compared to the consensus estimate of $2.15 billion. During the same quarter in the previous year, the firm posted $1.69 EPS. The business's revenue for the quarter was up 2.2% compared to the same quarter last year. Solventum has set its FY 2026 guidance at 7.100-7.200 EPS. As a group, sell-side analysts anticipate that Solventum Corporation will post 7.22 earnings per share for the current year.

Analysts Set New Price Targets

SOLV has been the subject of a number of research reports. BMO Capital Markets began coverage on shares of Solventum in a research note on Wednesday, July 8th. They set a "market perform" rating and a $81.00 target price for the company. Piper Sandler upped their price target on shares of Solventum from $92.00 to $105.00 and gave the company an "overweight" rating in a research note on Thursday, August 6th. BTIG Research increased their price target on shares of Solventum from $91.00 to $95.00 and gave the company a "buy" rating in a report on Thursday, August 6th. Mizuho set a $113.00 price objective on shares of Solventum in a research report on Thursday, August 6th. Finally, Weiss Ratings upgraded Solventum from a "hold (c+)" rating to a "buy (b-)" rating in a report on Tuesday, August 18th. Eight research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, Solventum presently has a consensus rating of "Moderate Buy" and an average price target of $91.64.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source